Treatment of psoriasis by pulsed dye lasers: short-term and long-term (4 years) results
Completed
- Conditions
- PsoriasisSkin and Connective Tissue Diseases
- Registration Number
- ISRCTN66115464
- Lead Sponsor
- Saint Louis Hospital (France)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 28
Inclusion Criteria
1. Both males and females, minimum age = 18, no upper age limit
2. Psoriasis: chronic and untreated plaques
Exclusion Criteria
1. Pregnant women
2. Minors
3. Patients who had received local treatment during the last month or oral treatment during the last 6 weeks (cyclosporin, retinoids, methotrexate, corticosteroids)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie pulsed dye laser therapy for psoriasis in ISRCTN66115464?
How does pulsed dye laser treatment compare to standard-of-care therapies for plaque psoriasis in long-term outcomes?
Are there specific biomarkers that predict response to pulsed dye laser therapy in psoriatic patients?
What are the potential adverse events associated with pulsed dye laser treatment for psoriasis and how are they managed?
What combination approaches or alternative laser therapies are being explored alongside pulsed dye lasers for psoriasis treatment?